Published at 05:29 (GMT) 21 Apr
Telegraph: British drug group AstraZeneca said to have rebuffed approach from America's Pfizer that would create £150bn behemoth.
British pharmaceuticals group AstraZeneca has received a preliminary approach from US peer Pfizer about a potential deal that could create an industry giant worth more than £150bn.
Talks are said to have taken place between Pfizer and Astra about a possible £60bn acquisition of the FTSE 100-listed company - though it is unclear whether the discussions are still live. Any deal between Pfizer, which makes anti-impotence drug Viagra and is valued at $193bn (£115bn), and Astra would create one the world's top 10 companies by market value. Astra, whose shares closed up 23 at £37.81½ on Thur, has a mkt cap of £47.7bn.
On FX, focus on the above pharma talks - though unclear whether it is still "live" as reported above. But could nevertheless see support for GBP/USD. GBP/USD at 1.6799-02, focus on 4-year 6-month highs of 1.6840-43, highest since November 2009. Eye any UK/US Pharma giants, corporate demand and speculators, Asian real money demand. Bids at 1.6750-60, offers 1.6810-20, weak stops above 1.6820-25. Then above 1.6850. Thin markets with most of Europe/UK away on Easter Monday.
EUR/GBP at 0.8222-25, eye break of 0.8200, given speculation of M+A demand, less hawkish BoE vs still dovish ECB. Offers 0.8240-50. WL
Recommended Content
Editors’ Picks
GBP/USD clings to recovery gains above 1.3200, as BoE looms
GBP/USD sustains the recovery above 1.3200 in early Europe on Thursday, having found buyers near 1.3150. A fresh US Dollar pullback and a rebound in risk sentiment offer support to the pair ahead of the BoE policy announcements.
EUR/USD holds higher ground above 1.1100, focus shifts to ECB-speak
EUR/USD is holding higher ground above 1.1100 in the early European session on Thursday. The pair is underpinned by the renewed US Dollar retreat, as traders digest the Fed's dovish outlook, bracing for ECB-speak for fresh trading incentives. US data are also eyed.
Gold price jumps back closer to all-time peak, $2,600 remains in sight amid fresh USD weakness
Gold price regains positive traction following the previous day's pullback from the all-time peak and builds on its steady intraday ascent heading into the European session on Thursday.
BoE expected to keep interest rate unchanged at 5% as price pressures persist
After a close call in August, the Bank of England’s September interest rate decision is keenly awaited for fresh cues on the bank’s future policy action and the pace of its bond sales.
Bitcoin surges to $62,000 mark after 50 bps Fed rate cut
Bitcoin and Ripple eye for a rally as they break and find support around their resistance barrier. Meanwhile, Ethereum demonstrates signs of recovery as it approaches a critical resistance level, indicating that an upward rally could be on the horizon if it successfully breaks through.
Moneta Markets review 2024: All you need to know
VERIFIED In this review, the FXStreet team provides an independent and thorough analysis based on direct testing and real experiences with Moneta Markets – an excellent broker for novice to intermediate forex traders who want to broaden their knowledge base.